Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

811
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
811
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

1.5K
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.5K
Anxiolytic Drugs: Overview01:26

Anxiolytic Drugs: Overview

867
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
867
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

2.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
2.5K
Hypertension V: Nursing Management01:23

Hypertension V: Nursing Management

226
The nursing management of hypertension involves accurately assessing symptoms, making a comprehensive nursing diagnosis, collaborating with patients to set goals, and implementing targeted interventions to mitigate the condition's impact and improve patient well-being.Comprehensive AssessmentThe initial step in nursing care for hypertension involves a thorough patient assessment. It includes evaluating symptoms such as headaches, dizziness, blurred vision, and previous hypertension episodes.
226
Management of Insomnia01:19

Management of Insomnia

424
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
424

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Rare hereditary and acquired diseases with parkinson's syndrome].

Fortschritte der Neurologie-Psychiatrie·2026
Same author

Measuring the Prodrome Promise and Challenges of the Prodromal Synucleinopathy Rating Scale.

Neurology·2026
Same author

Multiple system atrophy: integrating clinical phenotypes and multimodal biomarkers for early diagnosis.

Frontiers in aging neuroscience·2026
Same author

Body placement of inertial measurement units differentially affects physical activity assessment accuracy in drug-naïve Parkinson's disease.

Scientific reports·2026
Same author

Feasibility of short imaging protocols for [<sup>18</sup>F]fluordeprenyl-D2 PET in autoimmune encephalitis and multiple system atrophy.

European journal of nuclear medicine and molecular imaging·2026
Same author

Longitudinal monitoring of tau aggregation in progressive supranuclear palsy with [<sup>18</sup>F]PI-2620 PET.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026

Related Experiment Video

Updated: Dec 9, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.5K

Managing Essential Tremor.

Franziska Hopfner1,2, Günther Deuschl3

  • 1Department of Neurology, UKSH, Christian-Albrechts-University Kiel, Rosalind-Fraenklinstr. 10, 24105, Kiel, Germany.

Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|September 11, 2020
PubMed
Summary
This summary is machine-generated.

Essential tremor, a common neurological condition, requires a tailored management approach. This includes excluding treatable causes and considering symptomatic treatments like medication or advanced therapies such as deep brain stimulation for severe cases.

Keywords:
Tremordeep brain stimulationessential tremorfocused ultrasoundmanaging of essential tremortreatment of essential tremor

More Related Videos

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
04:05

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse

Published on: October 6, 2023

663
A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance
07:19

A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance

Published on: March 19, 2020

6.2K

Related Experiment Videos

Last Updated: Dec 9, 2025

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor
05:54

MRI-guided Focused Ultrasound Thalamotomy for Patients with Medically-refractory Essential Tremor

Published on: December 13, 2017

14.5K
Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse
04:05

Author Spotlight: Accurately Assessing Thyroid Hormone-Driven Motor Alterations in Mouse

Published on: October 6, 2023

663
A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance
07:19

A Modified Lean and Release Technique to Emphasize Response Inhibition and Action Selection in Reactive Balance

Published on: March 19, 2020

6.2K

Area of Science:

  • Neurology
  • Movement Disorders

Background:

  • Essential tremor is a prevalent tremor syndrome characterized by involuntary, rhythmic, oscillatory movements.
  • Tremor classification involves clinical features (Axis 1) and etiology (Axis 2).
  • Management strategies focus on excluding treatable causes and providing symptomatic relief.

Purpose of the Study:

  • To outline a comprehensive treatment algorithm for essential tremor.
  • To guide clinicians in selecting appropriate management strategies based on tremor severity and etiology.

Main Methods:

  • Review of current literature and established treatment guidelines for essential tremor.
  • Presentation of a structured treatment algorithm incorporating various therapeutic options.
  • Emphasis on shared decision-making between patients and clinicians.

Main Results:

  • Non-pharmacological interventions (occupational therapy, speech therapy, psychotherapy) can manage mild to moderate tremors.
  • First-line pharmacological treatments include propranolol, primidone, and topiramate.
  • Invasive treatments like deep brain stimulation and focused ultrasound thalamotomy are effective for severe essential tremor.

Conclusions:

  • A systematic approach is crucial for managing essential tremor, starting with excluding secondary causes.
  • Treatment selection should be individualized, considering tremor severity and patient preferences.
  • Advanced therapies offer significant improvements in tremor control and quality of life for severe cases.